145 related articles for article (PubMed ID: 15243687)
1. Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain. Description and associated factors. The Psychosp study.
Peiró S; Gómez G; Navarro M; Guadarrama I; Rejas J;
Soc Psychiatry Psychiatr Epidemiol; 2004 Jul; 39(7):507-13. PubMed ID: 15243687
[TBL] [Abstract][Full Text] [Related]
2. Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia.
Strutton DR; Gutierrez B; Blanchette CM
Am J Health Syst Pharm; 2008 Jan; 65(1):42-8. PubMed ID: 18159038
[TBL] [Abstract][Full Text] [Related]
3. [Evidence data and importance of public health of the new antipsychotics].
Launois R
Encephale; 2006 Oct; 32(5 Pt 3):S861-5. PubMed ID: 17119488
[No Abstract] [Full Text] [Related]
4. Audit of antipsychotic prescribing in a private psychiatric hospital.
Botvinik L; Ng C; Schweitzer I
Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.
Reid WH; Mason M
J Clin Psychiatry; 1998 Apr; 59(4):189-94. PubMed ID: 9590670
[TBL] [Abstract][Full Text] [Related]
6. [Consumption and cost of antipsychotic drugs].
Pérez J; Marín N; Vallano A; Castells X; Capellà D
Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Hospital Length and Cost of Stay in a National Sample of Adult Patients with Psychotic Disorders.
Bessaha ML; Shumway M; Smith ME; Bright CL; Unick GJ
Psychiatr Serv; 2017 Jun; 68(6):559-565. PubMed ID: 28142382
[TBL] [Abstract][Full Text] [Related]
9. Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.
Leung JG; Benedetti AM; Frazee LA; Myers N
Am J Ther; 2011 Jul; 18(4):300-4. PubMed ID: 20335789
[TBL] [Abstract][Full Text] [Related]
10. Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection.
Mesones-Peral JE; Gurillo-Muñoz P; Sánchez-Sicilia MP; Miller A; Griñant-Fernández A
Rev Psiquiatr Salud Ment; 2017; 10(1):33-37. PubMed ID: 27053545
[TBL] [Abstract][Full Text] [Related]
11. Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain.
Quintero J; Oyagüez I; González B; Cuervo-Arango I; García I; Casado MA
Clin Drug Investig; 2016 Jun; 36(6):479-90. PubMed ID: 27000061
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy.
Bera R; Offord S; Zubek D; Lau G; Lin J; Karson C
J Clin Psychopharmacol; 2014 Feb; 34(1):30-5. PubMed ID: 24135840
[TBL] [Abstract][Full Text] [Related]
13. The cost of relapse in schizophrenia and schizoaffective disorder.
Fitzgerald P; de Castella A; Arya D; Simons WR; Eggleston A; Meere S; Kulkarni J
Australas Psychiatry; 2009 Aug; 17(4):265-72. PubMed ID: 19585288
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.
Coley KC; Carter CS; DaPos SV; Maxwell R; Wilson JW; Branch RA
J Clin Psychiatry; 1999 Dec; 60(12):850-6. PubMed ID: 10665632
[TBL] [Abstract][Full Text] [Related]
15. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
17. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
Centorrino F; Fogarty KV; Sani G; Salvatore P; Cincotta SL; Hennen J; Guzzetta F; Talamo A; Saadeh MG; Baldessarini RJ
Hum Psychopharmacol; 2005 Oct; 20(7):485-92. PubMed ID: 16116665
[TBL] [Abstract][Full Text] [Related]
18. Trends of acute hepatitis B hospitalizations, comorbidities, fatality rate, and costs associated with the hospitalization in Spain (2001-2006).
Arteaga-Rodríguez A; Carrasco-Garrido P; Lopez de Andres A; Santos J; Gil de Miguel A; Jiménez-García R
Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):961-6. PubMed ID: 20168236
[TBL] [Abstract][Full Text] [Related]
19. Managing complex patients on a medical psychiatric unit: an observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention.
Leue C; Driessen G; Strik JJ; Drukker M; Stockbrügger RW; Kuijpers PM; Masclee AA; van Os J
J Psychosom Res; 2010 Mar; 68(3):295-302. PubMed ID: 20159217
[TBL] [Abstract][Full Text] [Related]
20. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
Taylor DM; Wright T; Libretto SE;
J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
